Ra Medical Systems Inc. (NYSE:RMED) does about 6.12M shares in volume on a normal day but saw 4366040 shares change hands in Tuesday trading. The company now has a market cap of 21.71M USD. Its current market price is $0.31, marking a decrease of -7.18% compared to the previous close of $0.34. The 52 week high reached by this stock is $2.69 whilst the lowest price level in 52 weeks is $0.28. The script in recent trading has seen the stock touch a high of $0.332 and a low of $0.31.

Ra Medical Systems Inc. (RMED) has a 20-day trading average at $0.3305 and the current price is -88.36% off the 52-week high compared with 13.37% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.3866 and its 200-day simple moving average is $1.0199. If we look at the stock’s price movements over the week, volatility stands at 9.35%, which increases to 11.17% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 41.65 to suggest the stock is neutral.

2 analysts observing the Ra Medical Systems Inc. (RMED) stock have set the 12-month price targets for the company’s shares at between $0.50 and $1.00. The median price target is 58.67% away from the current levels at $0.75.

FactSet Research has provided data showing that 2 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 1 have advised that investors hold their positions. The consensus recommendation rating is Overweight and Wall Street’s advice is for investors to Moderate Buy the stock.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on August 13, 2019 when Piper Jaffray downgraded the stock to “Neutral” and issued a price target of between $9 and $1.50.

The current price level is -5.10%, -20.17%, and -69.51% away from its SMA20, SMA50, and SMA200 respectively, with the RMED price moving above the 50-day SMA on September 01. Ra Medical Systems Inc. (RMED) stock is down -11.91% over the week and 8.12% over the past month. Its price is -72.31% year-to-date and -79.14% over the past year.

The stock last released its quarterly earnings report for quarter ended 6/29/2020, with the company’s earnings per share (EPS) of -$0.43 below consensus estimates by -$0.21. The company’s next earnings report is expected on 11/17/2020, with forecasts estimating quarterly EPS at -$0.13 and -$1 for whole year. RMED’s earnings per share are forecast to grow by 76.90% this year and 59.00% over next year. Expected sales for next quarter are $1.41 million, which analysts say will come at $4.76 million for the current fiscal year and next year at $7.03 million. In addition, estimates put the company’s current quarterly revenue at an average of $1.08 million.

Its 12-month price target is $0.75. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $0.50, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $1.00.

Outstanding shares total 72.47M with insiders holding 44.27% of the shares and institutional holders owning 18.57% of the company’s common stock. The company has a return on investment of -171.40% and return on equity of -140.20%. Price to book ratio is 0.27 and price to sales ratio is 3.88.

According to a U.S. Securities and Exchange Commission filing, Royce Opportunity Fund has added its position in Ra Medical Systems Inc. (RMED) to 186,823 shares, mirroring a recent increase by 33.09%. Royce Opportunity Fund added 46450.0 shares of Ra Medical Systems Inc. common stock bringing its total worth to about $54552.0 at the end of recent close, SEC documents show. Royce Opportunity Fund isn’t the only investment manager who changed stakes and is followed by Principal Investors – Small Cap F, which sold off 0.0 shares to end up with 226,500 shares worth $66138.0. Legg Mason Global Funds Plc – Roy raise their holdings by 20.03% in the company over the course of the most recent quarter. It now holds a 0.26% position in Ra Medical Systems Inc. thanks to 0.12 million shares amounting to $36040.0.